Physician profile
Darrell Baskin
NPI 1942322409
$13,276.91
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,101 · 2020: $578 · 2021: $2,127 · 2022: $8,888 · 2023: $261 · 2024: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $583.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| US Retina LLC | $10,687.77 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $829.39 | 2019 | |
| Notal Vision, INC. | $292.21 | 2021 | |
| Alcon Vision LLC | $222.46 | 2022-2024 | Constellation |
| Regeneron Healthcare Solutions, INC. | $210.37 | 2022-2024 | Eylea Hd, Eylea |
| Genentech USA, INC. | $185.68 | 2019-2023 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $178.86 | 2023 | Syfovre |
| Alimera Sciences, INC. | $127.82 | 2019-2023 | Iluvien |
| Astellas Pharma US INC | $127.12 | 2024 | Izervay |
| Optovue, INC. | $120.14 | 2019 | |
| Allergan, INC. | $109.11 | 2021 | |
| Eyepoint US, INC. | $94.07 | 2021-2022 | |
| Abbvie INC. | $26.73 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.25 | 2019 | |
| Bausch & Lomb Americas INC. | $23.92 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $17.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$30,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Baskin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.